<html>
<head>PUBMED IDs for ZFP90</head>
<body bgcolor='#C5F0F2'><h1>ZFP90</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21531788/'>Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes.</a> October 12  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21531783/'>Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer.</a> April 12  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22326525/'>16q22.1 microdeletion detected by array-CGH in a family with mental retardation and lobular breast cancer.</a> May 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24956270/'>Large-scale East-Asian eQTL mapping reveals novel candidate genes for LD mapping and the genomic landscape of transcriptional effects of sequence variants.</a> October 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24956267/'>Discordant diagnoses obtained by different approaches in antithrombin mutation analysis.</a> May 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24956262/'>Association between the catechol-O-methyltransferase (COMT) Val158Met polymorphism and manual aiming control in healthy subjects.</a> October 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27259261/'>CDH1 rs9929218 variant at 16q22.1 contributes to colorectal cancer susceptibility.</a> June 4  2016<br></body></html>
